Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.10 billion. The enterprise value is $814.75 million.
Market Cap | 1.10B |
Enterprise Value | 814.75M |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, before market open.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AUPH has 137.34 million shares outstanding. The number of shares has increased by 2.07% in one year.
Current Share Class | 137.34M |
Shares Outstanding | 137.34M |
Shares Change (YoY) | +2.07% |
Shares Change (QoQ) | +1.39% |
Owned by Insiders (%) | 2.03% |
Owned by Institutions (%) | 48.62% |
Float | 133.43M |
Valuation Ratios
The trailing PE ratio is 207.25 and the forward PE ratio is 17.83.
PE Ratio | 207.25 |
Forward PE | 17.83 |
PS Ratio | 5.04 |
Forward PS | 4.10 |
PB Ratio | 3.09 |
P/TBV Ratio | 2.93 |
P/FCF Ratio | 24.80 |
P/OCF Ratio | 24.64 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.49, with an EV/FCF ratio of 18.47.
EV / Earnings | 141.65 |
EV / Sales | 3.47 |
EV / EBITDA | 25.49 |
EV / EBIT | 65.08 |
EV / FCF | 18.47 |
Financial Position
The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.21.
Current Ratio | 4.57 |
Quick Ratio | 4.05 |
Debt / Equity | 0.21 |
Debt / EBITDA | 2.42 |
Debt / FCF | 1.80 |
Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is 1.52% and return on invested capital (ROIC) is 1.68%.
Return on Equity (ROE) | 1.52% |
Return on Assets (ROA) | 1.42% |
Return on Invested Capital (ROIC) | 1.68% |
Return on Capital Employed (ROCE) | 2.76% |
Revenue Per Employee | $1.81M |
Profits Per Employee | $44,246 |
Employee Count | 130 |
Asset Turnover | 0.43 |
Inventory Turnover | 1.24 |
Taxes
In the past 12 months, AUPH has paid $1.70 million in taxes.
Income Tax | 1.70M |
Effective Tax Rate | 22.77% |
Stock Price Statistics
The stock price has increased by +65.80% in the last 52 weeks. The beta is 1.27, so AUPH's price volatility has been higher than the market average.
Beta (5Y) | 1.27 |
52-Week Price Change | +65.80% |
50-Day Moving Average | 8.09 |
200-Day Moving Average | 7.35 |
Relative Strength Index (RSI) | 50.51 |
Average Volume (20 Days) | 1,593,811 |
Short Selling Information
The latest short interest is 11.44 million, so 8.33% of the outstanding shares have been sold short.
Short Interest | 11.44M |
Short Previous Month | 11.51M |
Short % of Shares Out | 8.33% |
Short % of Float | 8.57% |
Short Ratio (days to cover) | 6.18 |
Income Statement
In the last 12 months, AUPH had revenue of $235.13 million and earned $5.75 million in profits. Earnings per share was $0.04.
Revenue | 235.13M |
Gross Profit | 186.10M |
Operating Income | 12.52M |
Pretax Income | -48.10M |
Net Income | 5.75M |
EBITDA | 31.96M |
EBIT | 12.52M |
Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $358.44 million in cash and $79.37 million in debt, giving a net cash position of $279.07 million or $2.03 per share.
Cash & Cash Equivalents | 358.44M |
Total Debt | 79.37M |
Net Cash | 279.07M |
Net Cash Per Share | $2.03 |
Equity (Book Value) | 377.48M |
Book Value Per Share | 2.68 |
Working Capital | 348.83M |
Cash Flow
In the last 12 months, operating cash flow was $44.39 million and capital expenditures -$281,000, giving a free cash flow of $44.11 million.
Operating Cash Flow | 44.39M |
Capital Expenditures | -281,000 |
Free Cash Flow | 44.11M |
FCF Per Share | $0.32 |
Margins
Gross margin is 79.15%, with operating and profit margins of 5.32% and 2.45%.
Gross Margin | 79.15% |
Operating Margin | 5.32% |
Pretax Margin | 3.17% |
Profit Margin | 2.45% |
EBITDA Margin | 13.59% |
EBIT Margin | 5.32% |
FCF Margin | 18.76% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.07% |
Shareholder Yield | -2.07% |
Earnings Yield | 0.53% |
FCF Yield | 4.03% |
Analyst Forecast
The average price target for AUPH is $11.50, which is 43.93% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.50 |
Price Target Difference | 43.93% |
Analyst Consensus | Strong Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 11.56% |
EPS Growth Forecast (5Y) | 95.27% |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 0.02:1.
Last Split Date | Oct 23, 2013 |
Split Type | Reverse |
Split Ratio | 0.02:1 |
Scores
AUPH has an Altman Z-Score of 2.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.16 |
Piotroski F-Score | 6 |